|
|
|
42
|
35931
|
LAMICTAL 100MG TAB (GSK) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
103.30
|
3.44
|
TAB
|
60
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
3593G
|
APO-LAMOTRIGINE 100MG TAB (APO/COL)
|
LAMOTRIGINE
|
APO-LAMOTRIGINE
|
100'S
|
B
|
25.93
|
0.26
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
3593M
|
APO-LAMOTRIGINE 100MG TAB (APO) LAM (B)
|
LAMOTRIGINE
|
APO-LAMOTRIGINE
|
100'S
|
B
|
26.45
|
0.2645
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
3593N
|
LEMOGIN 100MG DISP TAB (JLP) LAMOTRIGINE
|
LAMOTRIGINE
|
LEMOGIN
|
20X10
|
B
|
25.82
|
0.13
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
3621B
|
APO-LEVOCARB 10MG | 100MG TAB (APO/COL)
|
CARBIDOPA|LEVODOPA
|
APO-LEVOCARB
|
100'S
|
A
|
17.26
|
0.17
|
TABLET
|
240
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-01
|
|
|
|
42
|
3621B
|
APO-LEVOCARB 10MG|100MG TAB (APO)
|
CARBIDOPA|LEVODOPA
|
APO-LEVOCARB
|
100'S
|
A
|
22.53
|
0.23
|
TAB
|
240
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
283616
|
DOPAMINE PRECURSORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
41
|
3621G
|
APO-LEVOCARB 10MG|100MG TAB (APO)
|
CARBIDOPA|LEVODOPA
|
APO-CARBIDOPA|LEVODOPA
|
100'S
|
A
|
22.53
|
0.2253
|
TAB
|
240
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
41
|
36222
|
SINEMET 25MG|250MG TAB (MSD) CARBIDOPA|L (C)
|
CARBIDOPA|LEVODOPA
|
SINEMET
|
100'S
|
C
|
79.97
|
0.7997
|
TAB
|
240
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
40
|
36223
|
PROLOPA 50MG | 200MG TAB (ROC/AHI) BENSERAZIDE |
|
BENSERAZIDE|LEVODOPA
|
PROLOPA
|
30'S
|
A
|
40.77
|
1.36
|
TABLET
|
240
|
TAB
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283616
|
DOPAMINE PRECURSORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
36223
|
PROLOPA 50MG|200MG TAB (ROC) BENSERAZIDE|LEVODOPA
|
BENSERAZIDE|LEVODOPA
|
PROLOPA
|
30'S
|
A
|
30.15
|
1.005
|
TAB
|
240
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-09-27
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
2024-09-27
|
|
|
|
40
|
36227
|
APO-LEVOCARB 25MG | 250MG TAB (APO/COL)
|
CARBIDOPA|LEVODOPA
|
APO-LEVOCARB
|
100'S
|
A
|
27.18
|
0.27
|
TABLET
|
240
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-01
|
|
|
|
41
|
3622K
|
CREDANIL 25MG|250MG TAB (REM) CARBIDOPA|
|
CARBIDOPA|LEVODOPA
|
CREDANIL
|
50'S
|
A
|
11.34
|
0.2267
|
TAB
|
240
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
42
|
3622K
|
CREDANIL 25MG|250MG TAB (REM) CARBIDOPA|LEVODOPA
|
CARBIDOPA|LEVODOPA
|
CREDANIL
|
50'S
|
A
|
11.42
|
0.23
|
TAB
|
240
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
41
|
3622R
|
APO-LEVOCARB 25MG|250MG TAB (APO)
|
CARBIDOPA|LEVODOPA
|
APO-CARBIDOPA|LEVODOPA
|
100'S
|
A
|
25.61
|
0.2561
|
TAB
|
240
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
42
|
3622V
|
BENKINSON 50MG|200MG CAP (INC) BENSERAZIDE|LEVODOPA
|
BENSERAZIDE|LEVODOPA
|
BENKINSON
|
20'S
|
A
|
15.71
|
0.79
|
CAP
|
240
|
BLIS
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283616
|
DOPAMINE PRECURSORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
|
|
|
|
40
|
3631AX
|
ACCORD METOCLOPRAMIDE 10MG TAB (INP/AAL) METO
|
METOCLOPRAMIDE
|
ACCORD METOCLOPRAMIDE
|
30'S
|
A
|
1.96
|
0.07
|
TABLET
|
90
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
3631BB
|
METOCLOPRAMIDE 10MG TAB (FSB/ATB)
|
METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
500'S
|
A
|
21.72
|
0.04
|
TABLET
|
90
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
41
|
3631BB
|
METOCLOPRAMIDE 10MG TAB (FSB)
|
METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
500'S
|
A
|
21.86
|
0.0437
|
TAB
|
90
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
GI PROKINETIC AGENTS
|
|
|
|
|
42
|
3631BC
|
MPRANIM 10MG TAB (ANC) METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
MPRANIM
|
500'S
|
A
|
8.70
|
0.02
|
TAB
|
90
|
BOTT
|
ANC
|
AEONIM HEALTHCARE
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
GI PROKINETIC AGENTS
|
|
|
|
|
40
|
3633AG
|
METOCLOPRAMIDE 5MG/ML IV/IM INJ (MON/PHA)
|
METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
10X2ML
|
B
|
6.01
|
0.60
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
GASTROINTESTINAL DRUGS
|
|